November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Treating metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis
However, Wegovy is a once-weekly injectable drug and some people thoroughly dislike injecting themselves
If your last meal is dinner at 6:00 PM and you go to bed at 10:00 PM, that gives your stomach 4 hours to process food before you lie down
Heres what to know about compounding pharmacies Jennie Smith, a seamstress at a ballet school in Kent, Ohio, had been trying to lose weight and keep it off for years
In the battle against diabetes mellitus, a global health threat, semaglutide has emerged as a potent weapon